610 related articles for article (PubMed ID: 7188381)
1. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
Schirrmacher V
Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.
Schirrmacher V; Landolfo S; Zawatzky R; Kirchner H
Invasion Metastasis; 1981; 1(3):175-94. PubMed ID: 6821364
[TBL] [Abstract][Full Text] [Related]
3. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
Kärre K; Klein GO; Kiessling R; Klein G
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
Sayles PC; Wassom DL
J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
[TBL] [Abstract][Full Text] [Related]
5. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
7. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
Altevogt P; Leidig S; Heckl-Oestreicher B
Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated arrest and reversal of established visceral metastases in athymic mice.
Wiltrout RH; Frost P; Morrison MK; Kerbel RS
Cancer Res; 1979 Oct; 39(10):4034-41. PubMed ID: 476640
[TBL] [Abstract][Full Text] [Related]
9. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
Ishikawa H; Kubota E; Saito K
J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
[TBL] [Abstract][Full Text] [Related]
10. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
Ozawa H; Iwaguchi T; Kataoka T
J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
Ryan JJ; Mond JJ; Finkelman FD
J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
[TBL] [Abstract][Full Text] [Related]
12. New immunodeficient mouse strains bred by introducing beige and xid mutations into the KSN nude strain.
Ishigaki Y; Hayakawa J; Hashimoto N; Nikaido H; Nikaido O
Lab Anim Sci; 1996 Aug; 46(4):418-24. PubMed ID: 8872993
[TBL] [Abstract][Full Text] [Related]
13. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
[TBL] [Abstract][Full Text] [Related]
14. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response.
Richie JP; McDonald J; Gittes RF
Surgery; 1981 Aug; 90(2):214-20. PubMed ID: 7256537
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of metastatic behavior of a human tumor cell line in athymic (nu/nu) and beige nude mice (bg/bg-nu/nu).
Fang WG; Wu BQ; Sun J; Yang JS; Wang JL; Zheng J
Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(4):189-92. PubMed ID: 2631114
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenicity of tumor cell populations: origin of a putative H-2 isoantigenic loss variant tumor.
Kerbel RS; Florian M; Man MS; Dennis J; McKenzie IF
J Natl Cancer Inst; 1980 May; 64(5):1221-30. PubMed ID: 6929020
[TBL] [Abstract][Full Text] [Related]
17. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
18. [Growth of human tumor transplanted into nude mice with various genetic backgrounds].
Kubota T; Asanuma F; Kurihara H; Konno H; Koh J; Inada T; Kubochi K; Watanabe M; Suzuki K; Ishibiki K
Gan To Kagaku Ryoho; 1984 Jan; 11(1):104-10. PubMed ID: 6538080
[TBL] [Abstract][Full Text] [Related]
19. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
20. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
